financetom
Business
financetom
/
Business
/
Market Chatter: ADM Reduces Workforce in Grain Trading Division
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: ADM Reduces Workforce in Grain Trading Division
Mar 26, 2025 4:11 AM

06:35 AM EDT, 03/26/2025 (MT Newswires) -- Archer-Daniels-Midland ( ADM ) is cutting jobs this week in its grain trading and oilseed processing division, Reuters reported Wednesday, citing sources familiar with the matter.

The company had announced in February plans to eliminate up to 700 positions and cut costs by $500 million to $750 million over the next several years, but it is unclear if the current layoffs are part of that plan, Reuters said.

The latest reductions reportedly began at ADM's European headquarters in Switzerland and are expected to affect its agricultural services and oilseeds operations, which oversee global crop trading, transportation, and processing.

Experienced traders are concerned about further layoffs, while another said the nutrition division does not appear to be impacted in this round of cuts, Reuters quoted one source as saying.

Archer-Daniels-Midland ( ADM ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Abeona Therapeutics Gets Permanent CMS J-Code for Zevaskyn Gene Therapy
Abeona Therapeutics Gets Permanent CMS J-Code for Zevaskyn Gene Therapy
Oct 30, 2025
02:10 PM EDT, 10/30/2025 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Thursday its autologous gene therapy Zevaskyn received a permanent Healthcare Common Procedure Coding System J-code from the Centers for Medicare and Medicaid Services. The new product-specific identifier, J3389 - Topical administration, prademagene zamikeracel, per treatment - will take effect on Jan. 1, 2026, the company added. Zevaskyn...
Roblox Lifts 2025 Bookings Outlook, Flags Margin Pressures Amid Higher Spending
Roblox Lifts 2025 Bookings Outlook, Flags Margin Pressures Amid Higher Spending
Oct 30, 2025
02:05 PM EDT, 10/30/2025 (MT Newswires) -- Roblox ( RBLX ) raised its full-year bookings guidance, while the video game platform flagged potential margin pressures from increased investments in infrastructure and people. For fiscal 2025, the company now expects bookings of $6.57 billion to $6.62 billion, representing growth of 50% to 51% year over year, up from its prior outlook...
--Louisiana-Pacific Keeps Quarterly Dividend at $0.28 a Share, Payable Nov. 21 to Holders of Record Nov. 14
--Louisiana-Pacific Keeps Quarterly Dividend at $0.28 a Share, Payable Nov. 21 to Holders of Record Nov. 14
Oct 30, 2025
02:10 PM EDT, 10/30/2025 (MT Newswires) -- Price: 89.32, Change: +0.23, Percent Change: +0.26 ...
AstraZeneca Gefurulimab Shows Positive Phase 3 Results in Myasthenia Gravis Trial
AstraZeneca Gefurulimab Shows Positive Phase 3 Results in Myasthenia Gravis Trial
Oct 30, 2025
02:01 PM EDT, 10/30/2025 (MT Newswires) -- AstraZeneca ( AZN ) reported positive results from its Phase 3 trial of gefurulimab, showing statistically significant and clinically meaningful improvements in patients' ability to perform daily activities with generalized Myasthenia Gravis, a chronic autoimmune neuromuscular disorder. The trial met its primary endpoint, demonstrating a significant improvement in the Myasthenia Gravis Activities of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved